chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Amnesia, Confusional state, Disorientation, Fall, Head injury
Clinical narrative: The first 3 minutes from the time of vaccination, client did not have adverse event.  RN was doing rounds checking on other vaccinated clients when client waved for RN?s attention. RN approached client and immediately thereafter, client fell off the chair and landed on the sidewalk face first hitting left side of his head on the floor. RN repositioned the client to supine position supporting him from the back. Client was out for approx. 5sec, RN attempted to arouse him and was successful. Client woke up, eyes dilated, diaphoretic, unaware of his location, appeared disoriented. At 1000, first vital reading was performed BP 142/60, P102, O2sat 97%, R20. RN reoriented client explaining what happened and informed him that we will activate EMS, client refused at this time. At 1005, second vital reading was performed BP 136/62, P72, O2sat 99%, R18. Client was verbally engaging with staff, RN attended to a mild abrasion on his left temple cleansed with alcohol swab and placed a band aid. Client was offered water but declined. RN was supporting client in supine position and continued assessing his health status.  At 1006 EMS was activated by staff and informed client.  Client continues to verbalize refusal and provided teaching and safety protocol, verbally understands.  At 1010, third vital reading was 120/52, P70, O2sat 98%, R18. Client was feeling nauseated and was diaphoretic upon assessment. Client requested to stand up to walk to the trash can. Assisted in a standing position with two additional staff surrounding him and assisted him to the trash can where he had x1 vomit of emesis.  RN was beside the client monitoring his status.  At 1017, fourth vital reading was performed 115/60, P78, O2sat 98%, R18. Client had a second episode of vomiting in the trash and continue to be diaphoretic, pale in color. Client called his friend to pick him up. RN maintained in proximity of client and assessed his memory of the event for possible concussion. Client appeared to remember his vaccination experience leading up to syncopal episode. Client could not remember where he?s at.  At 1027, EMS arrived on the scene and RN gave report.  EMS conducted their assessment, client refused services. At 1035, client?s friend arrived at the event and picked him up.  Provided education to client to go to PCP and get checked out for possible concussion, verbally acknowledge.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Loss of consciousness, Mydriasis, Nausea, Pallor
Clinical narrative: The first 3 minutes from the time of vaccination, client did not have adverse event.  RN was doing rounds checking on other vaccinated clients when client waved for RN?s attention. RN approached client and immediately thereafter, client fell off the chair and landed on the sidewalk face first hitting left side of his head on the floor. RN repositioned the client to supine position supporting him from the back. Client was out for approx. 5sec, RN attempted to arouse him and was successful. Client woke up, eyes dilated, diaphoretic, unaware of his location, appeared disoriented. At 1000, first vital reading was performed BP 142/60, P102, O2sat 97%, R20. RN reoriented client explaining what happened and informed him that we will activate EMS, client refused at this time. At 1005, second vital reading was performed BP 136/62, P72, O2sat 99%, R18. Client was verbally engaging with staff, RN attended to a mild abrasion on his left temple cleansed with alcohol swab and placed a band aid. Client was offered water but declined. RN was supporting client in supine position and continued assessing his health status.  At 1006 EMS was activated by staff and informed client.  Client continues to verbalize refusal and provided teaching and safety protocol, verbally understands.  At 1010, third vital reading was 120/52, P70, O2sat 98%, R18. Client was feeling nauseated and was diaphoretic upon assessment. Client requested to stand up to walk to the trash can. Assisted in a standing position with two additional staff surrounding him and assisted him to the trash can where he had x1 vomit of emesis.  RN was beside the client monitoring his status.  At 1017, fourth vital reading was performed 115/60, P78, O2sat 98%, R18. Client had a second episode of vomiting in the trash and continue to be diaphoretic, pale in color. Client called his friend to pick him up. RN maintained in proximity of client and assessed his memory of the event for possible concussion. Client appeared to remember his vaccination experience leading up to syncopal episode. Client could not remember where he?s at.  At 1027, EMS arrived on the scene and RN gave report.  EMS conducted their assessment, client refused services. At 1035, client?s friend arrived at the event and picked him up.  Provided education to client to go to PCP and get checked out for possible concussion, verbally acknowledge.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Skin abrasion, Syncope, Vomiting
Clinical narrative: The first 3 minutes from the time of vaccination, client did not have adverse event.  RN was doing rounds checking on other vaccinated clients when client waved for RN?s attention. RN approached client and immediately thereafter, client fell off the chair and landed on the sidewalk face first hitting left side of his head on the floor. RN repositioned the client to supine position supporting him from the back. Client was out for approx. 5sec, RN attempted to arouse him and was successful. Client woke up, eyes dilated, diaphoretic, unaware of his location, appeared disoriented. At 1000, first vital reading was performed BP 142/60, P102, O2sat 97%, R20. RN reoriented client explaining what happened and informed him that we will activate EMS, client refused at this time. At 1005, second vital reading was performed BP 136/62, P72, O2sat 99%, R18. Client was verbally engaging with staff, RN attended to a mild abrasion on his left temple cleansed with alcohol swab and placed a band aid. Client was offered water but declined. RN was supporting client in supine position and continued assessing his health status.  At 1006 EMS was activated by staff and informed client.  Client continues to verbalize refusal and provided teaching and safety protocol, verbally understands.  At 1010, third vital reading was 120/52, P70, O2sat 98%, R18. Client was feeling nauseated and was diaphoretic upon assessment. Client requested to stand up to walk to the trash can. Assisted in a standing position with two additional staff surrounding him and assisted him to the trash can where he had x1 vomit of emesis.  RN was beside the client monitoring his status.  At 1017, fourth vital reading was performed 115/60, P78, O2sat 98%, R18. Client had a second episode of vomiting in the trash and continue to be diaphoretic, pale in color. Client called his friend to pick him up. RN maintained in proximity of client and assessed his memory of the event for possible concussion. Client appeared to remember his vaccination experience leading up to syncopal episode. Client could not remember where he?s at.  At 1027, EMS arrived on the scene and RN gave report.  EMS conducted their assessment, client refused services. At 1035, client?s friend arrived at the event and picked him up.  Provided education to client to go to PCP and get checked out for possible concussion, verbally acknowledge.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Echocardiogram normal, Electrocardiogram normal, Troponin
Clinical narrative: 4 days after the 2nd dose of the Pfzer vaccine had chest Pain for 2 hours.  Patient seen by PMD and sent for Troponin which was mildly elevated, and sent for an ECG at urgent care.  Had a normal ECG at urgent care but told to go to the ER.  In the ER was well appearing with no chest pain.  Had a repeat ECG which was normal.  Troponin  repeated and very mildly elevated. She was discharged from the ER on Motrin 600mg PO TID, and had cardiology outpatient follow-up set-up within 48 hours with me.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acoustic stimulation tests, Blood test, Computerised tomogram, Deafness, Magnetic resonance imaging
Clinical narrative: I lost hearing all hearing and developed tinnitus (loud ringing) in my right ear on the morning of Feb 15 (three days after receiving my first dose of the Moderna covid vaccine).
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: I lost hearing all hearing and developed tinnitus (loud ringing) in my right ear on the morning of Feb 15 (three days after receiving my first dose of the Moderna covid vaccine).
Age: 55.0
Sex: F
Vaccine: PPV
Symptoms: Expired product administered
Clinical narrative: During routine monthly inventory in the immunization clinic an expired PPSV23 (pneumovax 23 vaccine) box was discovered.  The box was missing 7 vials.  It is unsure when the vials were used.  They could have been used prior to the expiration date, but that could not be verified.  A report from 9 Jan 2022 to 4 Mar 2022 was pulled and there was 9 doses of PPSV23 given.  The lot numbers as recorded in the EMR matched a valid, unexpired box.  It is possible that expired doses were given, but it is also possible that no expired doses were given.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Night sweats, Pain
Clinical narrative: Fever, chills, night sweat, loss of appetite, body aches, extreme fatigue.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever, chills, night sweat, loss of appetite, body aches, extreme fatigue.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Hypovolaemia, Laboratory test abnormal, Renal injury
Clinical narrative: Hypovolemia, dehydration, acute renal injury d/t hypovolemiaLabs
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Confusional state, Dyspnoea, Haemodialysis, Influenza A virus test negative
Clinical narrative: Patient is a89y.o. year old  female with a h/o anemia, ESRD on HD presented to facility on 1/1/2022 from HD secondary to shortness of breath halfway through her session with pulse ox of 74%. Patient confused and unable to provide further history. Reportedly tested positive for COVID recently, however there is no record of positive testing in our system or other system. Last negative test recorded 11/6/2021. Attempts to reach family to clarify unsuccessful .
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza B virus test, Respiratory syncytial virus test negative, SARS-CoV-2 test positive, Therapy interrupted
Clinical narrative: Patient is a89y.o. year old  female with a h/o anemia, ESRD on HD presented to facility on 1/1/2022 from HD secondary to shortness of breath halfway through her session with pulse ox of 74%. Patient confused and unable to provide further history. Reportedly tested positive for COVID recently, however there is no record of positive testing in our system or other system. Last negative test recorded 11/6/2021. Attempts to reach family to clarify unsuccessful .
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia
Clinical narrative: Admit COVID-19 PNA.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram ambulatory abnormal, Extrasystoles, Palpitations, Ventricular extrasystoles
Clinical narrative: Heart palpitations and skipping beats. Ongoing problem.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Headache, Palpitations, Product preparation error, Tachycardia
Clinical narrative: Patient received the Pfizer purple vail whole dose without diluent on 12/9/2021. On 12/9/21 VAERS report has been completed and # is 740048. Patient came to see the provider on 02/07/2022. Complains of intermittent chest pain/palpitations. Associate symptoms include headache and tachycardia.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Lymphadenopathy
Clinical narrative: Pt. states that after receiving the 3rd dose of Phizer 01/18/2022, started experiencing symptoms that evening of (Right) arm Lymphnoid swelling, headache, and chills (Lasting 24hrs). No noted Primary visit/communications.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Chest discomfort, Chest pain
Clinical narrative: At 30 minutes post administration I developed a right sided headache. At 45 minutes post injection I developed right sided neck, arm, and back pain. During the night post administration I developed a racing heart which awoke me out of my sleep with associated tight/crushing chest pain. This lasted part of the night while the rest of the night I had severe night sweats and then chills in the morning. During the day I had significant weakness, fatigue, body aches, joint pain of the right hand, and depression. On the evening of 2/8 I had significant right sided back pain.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Depression, Fatigue, Headache, Neck pain
Clinical narrative: At 30 minutes post administration I developed a right sided headache. At 45 minutes post injection I developed right sided neck, arm, and back pain. During the night post administration I developed a racing heart which awoke me out of my sleep with associated tight/crushing chest pain. This lasted part of the night while the rest of the night I had severe night sweats and then chills in the morning. During the day I had significant weakness, fatigue, body aches, joint pain of the right hand, and depression. On the evening of 2/8 I had significant right sided back pain.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Night sweats, Pain, Pain in extremity, Palpitations, Sleep disorder
Clinical narrative: At 30 minutes post administration I developed a right sided headache. At 45 minutes post injection I developed right sided neck, arm, and back pain. During the night post administration I developed a racing heart which awoke me out of my sleep with associated tight/crushing chest pain. This lasted part of the night while the rest of the night I had severe night sweats and then chills in the morning. During the day I had significant weakness, fatigue, body aches, joint pain of the right hand, and depression. On the evening of 2/8 I had significant right sided back pain.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: The patient has not experience any adverse events, but the vaccine was inadvertently administered within 1 month of the patient receiving monoclonal antibody therapy (BAM infusion) for COVID-19. The facility that provided the patient's information did not indicate he had received the infusion, yet after vaccination they reported he had in fact received the BAM infusion on 1/4/22.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient received the 5-11 year old dose and was 12 at time of second Pfizer vaccination.
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given one day past use by date in the refrigerator.  Pfizer notified.  Physician notified then notified parent.  no further action at this time
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Echocardiogram, Extrasystoles, Headache
Clinical narrative: (1) Sudden onset right-sided headache, daily for weeks, subsiding to every other day, then 2-3 days a week, then weekly, then monthly , finally stopped in November 2021. Recurrent episode February 4 x1 .  Vision in Right eye feels like it is worsening. Also, (2) In October 2021, sensation of heart skipping beats, heart racing, shortness of breath, slight dizziness.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Pericardial effusion, Visual impairment
Clinical narrative: (1) Sudden onset right-sided headache, daily for weeks, subsiding to every other day, then 2-3 days a week, then weekly, then monthly , finally stopped in November 2021. Recurrent episode February 4 x1 .  Vision in Right eye feels like it is worsening. Also, (2) In October 2021, sensation of heart skipping beats, heart racing, shortness of breath, slight dizziness.
Age: 58.0
Sex: U
Vaccine: COVID19
Symptoms: COVID-19 pneumonia
Clinical narrative: Admit COVID-19 PNA.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Brain natriuretic peptide normal, Chest X-ray abnormal, Cough, Discomfort
Clinical narrative: This is a 79y.o. male with a pmh of HFpEF, COPD, obesity, vertigo, and HTN who presented to the ED for complaint of "feeling off". He states that last night he had difficulty sleeping because he could not get comfortable and he knew "something was wrong" and decided to seek further intervention at our facility. He states that he is SOB but this is unchanged over the past 2-3 months. He admits to a cough for the past 2-3 months. He states his SOB has not been worsening over the past few days.States his chronic cough is non-productive.  Admits to b/l LE swelling with R>L which has been an ongoing issue for months. He states he tripped and hit his right knee but denies head trauma. He denies any fevers, chills, chest pain, sob, adominal pain, nvd.  He states he was vaccinated for covid 19 in 03/2021. Cannot recall which vaccine. He did not get his booster. He has a history of COPD but is not on home O2 or any inhalers. He denies any fevers, chills, chest pain, sob, nvd, orthopnea. Denies tobacco, etoh, or illicit drug use.    In the ED, BP 141/88, HR 106, RR 22, spo2 90% on RA. Afebrile. CXR revealed left sided parenchymal reticular and groundglass densities suggesting pneumonia. ECG revealed sinus tachycardia with 108 with PVC and no ST changes. Labs significant for Plt 132, BG 105, PT/INR 14.5/1.3. BNP wnl. Troponin neg x1. Patient was started on 2L NC with improvement of sp2 to 96%. He was administered albuterol inhaler x1, duoneb x1, and decadron 6 mg IVP x1. Patient was admitted with consult to ID placed for management of covid 19.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram abnormal, Fall, Feeling abnormal, Insomnia
Clinical narrative: This is a 79y.o. male with a pmh of HFpEF, COPD, obesity, vertigo, and HTN who presented to the ED for complaint of "feeling off". He states that last night he had difficulty sleeping because he could not get comfortable and he knew "something was wrong" and decided to seek further intervention at our facility. He states that he is SOB but this is unchanged over the past 2-3 months. He admits to a cough for the past 2-3 months. He states his SOB has not been worsening over the past few days.States his chronic cough is non-productive.  Admits to b/l LE swelling with R>L which has been an ongoing issue for months. He states he tripped and hit his right knee but denies head trauma. He denies any fevers, chills, chest pain, sob, adominal pain, nvd.  He states he was vaccinated for covid 19 in 03/2021. Cannot recall which vaccine. He did not get his booster. He has a history of COPD but is not on home O2 or any inhalers. He denies any fevers, chills, chest pain, sob, nvd, orthopnea. Denies tobacco, etoh, or illicit drug use.    In the ED, BP 141/88, HR 106, RR 22, spo2 90% on RA. Afebrile. CXR revealed left sided parenchymal reticular and groundglass densities suggesting pneumonia. ECG revealed sinus tachycardia with 108 with PVC and no ST changes. Labs significant for Plt 132, BG 105, PT/INR 14.5/1.3. BNP wnl. Troponin neg x1. Patient was started on 2L NC with improvement of sp2 to 96%. He was administered albuterol inhaler x1, duoneb x1, and decadron 6 mg IVP x1. Patient was admitted with consult to ID placed for management of covid 19.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: International normalised ratio increased, Joint injury, Lung opacity, Peripheral swelling, Platelet count decreased
Clinical narrative: This is a 79y.o. male with a pmh of HFpEF, COPD, obesity, vertigo, and HTN who presented to the ED for complaint of "feeling off". He states that last night he had difficulty sleeping because he could not get comfortable and he knew "something was wrong" and decided to seek further intervention at our facility. He states that he is SOB but this is unchanged over the past 2-3 months. He admits to a cough for the past 2-3 months. He states his SOB has not been worsening over the past few days.States his chronic cough is non-productive.  Admits to b/l LE swelling with R>L which has been an ongoing issue for months. He states he tripped and hit his right knee but denies head trauma. He denies any fevers, chills, chest pain, sob, adominal pain, nvd.  He states he was vaccinated for covid 19 in 03/2021. Cannot recall which vaccine. He did not get his booster. He has a history of COPD but is not on home O2 or any inhalers. He denies any fevers, chills, chest pain, sob, nvd, orthopnea. Denies tobacco, etoh, or illicit drug use.    In the ED, BP 141/88, HR 106, RR 22, spo2 90% on RA. Afebrile. CXR revealed left sided parenchymal reticular and groundglass densities suggesting pneumonia. ECG revealed sinus tachycardia with 108 with PVC and no ST changes. Labs significant for Plt 132, BG 105, PT/INR 14.5/1.3. BNP wnl. Troponin neg x1. Patient was started on 2L NC with improvement of sp2 to 96%. He was administered albuterol inhaler x1, duoneb x1, and decadron 6 mg IVP x1. Patient was admitted with consult to ID placed for management of covid 19.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Prothrombin time prolonged, SARS-CoV-2 test, Sinus tachycardia, Troponin normal
Clinical narrative: This is a 79y.o. male with a pmh of HFpEF, COPD, obesity, vertigo, and HTN who presented to the ED for complaint of "feeling off". He states that last night he had difficulty sleeping because he could not get comfortable and he knew "something was wrong" and decided to seek further intervention at our facility. He states that he is SOB but this is unchanged over the past 2-3 months. He admits to a cough for the past 2-3 months. He states his SOB has not been worsening over the past few days.States his chronic cough is non-productive.  Admits to b/l LE swelling with R>L which has been an ongoing issue for months. He states he tripped and hit his right knee but denies head trauma. He denies any fevers, chills, chest pain, sob, adominal pain, nvd.  He states he was vaccinated for covid 19 in 03/2021. Cannot recall which vaccine. He did not get his booster. He has a history of COPD but is not on home O2 or any inhalers. He denies any fevers, chills, chest pain, sob, nvd, orthopnea. Denies tobacco, etoh, or illicit drug use.    In the ED, BP 141/88, HR 106, RR 22, spo2 90% on RA. Afebrile. CXR revealed left sided parenchymal reticular and groundglass densities suggesting pneumonia. ECG revealed sinus tachycardia with 108 with PVC and no ST changes. Labs significant for Plt 132, BG 105, PT/INR 14.5/1.3. BNP wnl. Troponin neg x1. Patient was started on 2L NC with improvement of sp2 to 96%. He was administered albuterol inhaler x1, duoneb x1, and decadron 6 mg IVP x1. Patient was admitted with consult to ID placed for management of covid 19.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Ventricular extrasystoles
Clinical narrative: This is a 79y.o. male with a pmh of HFpEF, COPD, obesity, vertigo, and HTN who presented to the ED for complaint of "feeling off". He states that last night he had difficulty sleeping because he could not get comfortable and he knew "something was wrong" and decided to seek further intervention at our facility. He states that he is SOB but this is unchanged over the past 2-3 months. He admits to a cough for the past 2-3 months. He states his SOB has not been worsening over the past few days.States his chronic cough is non-productive.  Admits to b/l LE swelling with R>L which has been an ongoing issue for months. He states he tripped and hit his right knee but denies head trauma. He denies any fevers, chills, chest pain, sob, adominal pain, nvd.  He states he was vaccinated for covid 19 in 03/2021. Cannot recall which vaccine. He did not get his booster. He has a history of COPD but is not on home O2 or any inhalers. He denies any fevers, chills, chest pain, sob, nvd, orthopnea. Denies tobacco, etoh, or illicit drug use.    In the ED, BP 141/88, HR 106, RR 22, spo2 90% on RA. Afebrile. CXR revealed left sided parenchymal reticular and groundglass densities suggesting pneumonia. ECG revealed sinus tachycardia with 108 with PVC and no ST changes. Labs significant for Plt 132, BG 105, PT/INR 14.5/1.3. BNP wnl. Troponin neg x1. Patient was started on 2L NC with improvement of sp2 to 96%. He was administered albuterol inhaler x1, duoneb x1, and decadron 6 mg IVP x1. Patient was admitted with consult to ID placed for management of covid 19.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Patient is immunocompromised and should have received 3rd full dose in primary series.  Patient only received booster dose (half dose).  Patient to return to injection clinic to receive remaining dose.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: EXPIRED VACCINE IS ADMINISTERED DUE TO MISUNDERSTANDING WHEN STABLISHING THE EXPIRATION DATE IN THE "PRIVATE" REPORT.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, Blood gases, C-reactive protein increased, COVID-19
Clinical narrative: Patient is a 69 yo F with PMH OSA, HTN, HLD, hypothyroidism, and depression who presents as an Outside facility information: I do not have phone number of hospital or a list of providers who cared for the patient at facility transfer for acute hypoxic respiratory failure due to COVID pneumonia requiring intubation. Patient is intubated / sedated with no family at bedside. History was obtained via chart review.    Patient had about 1 week of dyspnea, headache, fevers, cough, and nausea and was found to be COVID-19 positive on 12/8. Of note, patient was vaccinated with one dose of J&J vaccine. She was prescribed Decadron 4 mg daily, doxycycline, and an albuterol inhaler but failed to improve. She presented to Hospital on 12/12 and was found to be hypoxic with SaO2 76%. On admission, WBC 13K, CRP 17. CXR with b/l airspace disease. Her TTE showed EF 60%, mild LVH, normal left and right ventricular function. She was admitted to the Hospital ICU and started on remdesivir and continued on decadron. She was initially on 100% HFNC with ABG 7.43/46/81.   She clinically worsened on 12/12 with increased O2 requirements and received one dose of Amcetra 8 mg/kg. She was also started on ceftriaxone and azithromycin on 12/12. She continued to worsen and antibiotics were broadened to Levaquin and meropenem on 12/21. She was also started on therapeutic lovenox for suspected PE. She did not undergo a CT PE due to clinical instability. She was transitioned to BiPAP and then intubated on 12/22 for worsening hypoxia. She developed hypotension on propofol and was switched to versed and fentanyl drips for sedation and analgesia. She was also given midodrine for the hypotension.   On arrival to Higher Level of Care Facility, patient was on FiO2 100% and PEEP 10 with SaO2 in mid 90s. She was normotensive on fentanyl and versed drips.  Patient is a 69 y.o. female presenting from facility with AHRF on MV (Intubated 12/22) d/t COVID-19 PNA/ARDS (+12/8). Extubated on 1/5. Required reintubation 1/7 for respiratory distress. Course complicated by MRSA bacteremia, MRSA PNA, and right sided pneumothorax requiring chest tube 1/17.   Dexamethasone (10 IV daily, day 15 on transfer), Remdesivir (s/p 10d), Toci (x1 dose), Rocephin/Zitro for CAP coverage -> decompensated on 12/21, ABX broadened to Levaquin/Merrem (day 15 total of ABX on transfer), empirically treated for PE w/ tLov -> intubated 12/22, developed sedation-related hypotension and started on Midorine   Patient's clinical course continued to worsen. She required CRRT and continued to required pressors and high ventilator settings. Patient's family made the decision to make patient DNR and transition to comfort care. She passed away with family at her bedside.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Chest tube insertion, Cough, Death
Clinical narrative: Patient is a 69 yo F with PMH OSA, HTN, HLD, hypothyroidism, and depression who presents as an Outside facility information: I do not have phone number of hospital or a list of providers who cared for the patient at facility transfer for acute hypoxic respiratory failure due to COVID pneumonia requiring intubation. Patient is intubated / sedated with no family at bedside. History was obtained via chart review.    Patient had about 1 week of dyspnea, headache, fevers, cough, and nausea and was found to be COVID-19 positive on 12/8. Of note, patient was vaccinated with one dose of J&J vaccine. She was prescribed Decadron 4 mg daily, doxycycline, and an albuterol inhaler but failed to improve. She presented to Hospital on 12/12 and was found to be hypoxic with SaO2 76%. On admission, WBC 13K, CRP 17. CXR with b/l airspace disease. Her TTE showed EF 60%, mild LVH, normal left and right ventricular function. She was admitted to the Hospital ICU and started on remdesivir and continued on decadron. She was initially on 100% HFNC with ABG 7.43/46/81.   She clinically worsened on 12/12 with increased O2 requirements and received one dose of Amcetra 8 mg/kg. She was also started on ceftriaxone and azithromycin on 12/12. She continued to worsen and antibiotics were broadened to Levaquin and meropenem on 12/21. She was also started on therapeutic lovenox for suspected PE. She did not undergo a CT PE due to clinical instability. She was transitioned to BiPAP and then intubated on 12/22 for worsening hypoxia. She developed hypotension on propofol and was switched to versed and fentanyl drips for sedation and analgesia. She was also given midodrine for the hypotension.   On arrival to Higher Level of Care Facility, patient was on FiO2 100% and PEEP 10 with SaO2 in mid 90s. She was normotensive on fentanyl and versed drips.  Patient is a 69 y.o. female presenting from facility with AHRF on MV (Intubated 12/22) d/t COVID-19 PNA/ARDS (+12/8). Extubated on 1/5. Required reintubation 1/7 for respiratory distress. Course complicated by MRSA bacteremia, MRSA PNA, and right sided pneumothorax requiring chest tube 1/17.   Dexamethasone (10 IV daily, day 15 on transfer), Remdesivir (s/p 10d), Toci (x1 dose), Rocephin/Zitro for CAP coverage -> decompensated on 12/21, ABX broadened to Levaquin/Merrem (day 15 total of ABX on transfer), empirically treated for PE w/ tLov -> intubated 12/22, developed sedation-related hypotension and started on Midorine   Patient's clinical course continued to worsen. She required CRRT and continued to required pressors and high ventilator settings. Patient's family made the decision to make patient DNR and transition to comfort care. She passed away with family at her bedside.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Echocardiogram, Endotracheal intubation, Headache, Hypotension
Clinical narrative: Patient is a 69 yo F with PMH OSA, HTN, HLD, hypothyroidism, and depression who presents as an Outside facility information: I do not have phone number of hospital or a list of providers who cared for the patient at facility transfer for acute hypoxic respiratory failure due to COVID pneumonia requiring intubation. Patient is intubated / sedated with no family at bedside. History was obtained via chart review.    Patient had about 1 week of dyspnea, headache, fevers, cough, and nausea and was found to be COVID-19 positive on 12/8. Of note, patient was vaccinated with one dose of J&J vaccine. She was prescribed Decadron 4 mg daily, doxycycline, and an albuterol inhaler but failed to improve. She presented to Hospital on 12/12 and was found to be hypoxic with SaO2 76%. On admission, WBC 13K, CRP 17. CXR with b/l airspace disease. Her TTE showed EF 60%, mild LVH, normal left and right ventricular function. She was admitted to the Hospital ICU and started on remdesivir and continued on decadron. She was initially on 100% HFNC with ABG 7.43/46/81.   She clinically worsened on 12/12 with increased O2 requirements and received one dose of Amcetra 8 mg/kg. She was also started on ceftriaxone and azithromycin on 12/12. She continued to worsen and antibiotics were broadened to Levaquin and meropenem on 12/21. She was also started on therapeutic lovenox for suspected PE. She did not undergo a CT PE due to clinical instability. She was transitioned to BiPAP and then intubated on 12/22 for worsening hypoxia. She developed hypotension on propofol and was switched to versed and fentanyl drips for sedation and analgesia. She was also given midodrine for the hypotension.   On arrival to Higher Level of Care Facility, patient was on FiO2 100% and PEEP 10 with SaO2 in mid 90s. She was normotensive on fentanyl and versed drips.  Patient is a 69 y.o. female presenting from facility with AHRF on MV (Intubated 12/22) d/t COVID-19 PNA/ARDS (+12/8). Extubated on 1/5. Required reintubation 1/7 for respiratory distress. Course complicated by MRSA bacteremia, MRSA PNA, and right sided pneumothorax requiring chest tube 1/17.   Dexamethasone (10 IV daily, day 15 on transfer), Remdesivir (s/p 10d), Toci (x1 dose), Rocephin/Zitro for CAP coverage -> decompensated on 12/21, ABX broadened to Levaquin/Merrem (day 15 total of ABX on transfer), empirically treated for PE w/ tLov -> intubated 12/22, developed sedation-related hypotension and started on Midorine   Patient's clinical course continued to worsen. She required CRRT and continued to required pressors and high ventilator settings. Patient's family made the decision to make patient DNR and transition to comfort care. She passed away with family at her bedside.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoxia, Intensive care, Left ventricular hypertrophy, Lung disorder, Mechanical ventilation
Clinical narrative: Patient is a 69 yo F with PMH OSA, HTN, HLD, hypothyroidism, and depression who presents as an Outside facility information: I do not have phone number of hospital or a list of providers who cared for the patient at facility transfer for acute hypoxic respiratory failure due to COVID pneumonia requiring intubation. Patient is intubated / sedated with no family at bedside. History was obtained via chart review.    Patient had about 1 week of dyspnea, headache, fevers, cough, and nausea and was found to be COVID-19 positive on 12/8. Of note, patient was vaccinated with one dose of J&J vaccine. She was prescribed Decadron 4 mg daily, doxycycline, and an albuterol inhaler but failed to improve. She presented to Hospital on 12/12 and was found to be hypoxic with SaO2 76%. On admission, WBC 13K, CRP 17. CXR with b/l airspace disease. Her TTE showed EF 60%, mild LVH, normal left and right ventricular function. She was admitted to the Hospital ICU and started on remdesivir and continued on decadron. She was initially on 100% HFNC with ABG 7.43/46/81.   She clinically worsened on 12/12 with increased O2 requirements and received one dose of Amcetra 8 mg/kg. She was also started on ceftriaxone and azithromycin on 12/12. She continued to worsen and antibiotics were broadened to Levaquin and meropenem on 12/21. She was also started on therapeutic lovenox for suspected PE. She did not undergo a CT PE due to clinical instability. She was transitioned to BiPAP and then intubated on 12/22 for worsening hypoxia. She developed hypotension on propofol and was switched to versed and fentanyl drips for sedation and analgesia. She was also given midodrine for the hypotension.   On arrival to Higher Level of Care Facility, patient was on FiO2 100% and PEEP 10 with SaO2 in mid 90s. She was normotensive on fentanyl and versed drips.  Patient is a 69 y.o. female presenting from facility with AHRF on MV (Intubated 12/22) d/t COVID-19 PNA/ARDS (+12/8). Extubated on 1/5. Required reintubation 1/7 for respiratory distress. Course complicated by MRSA bacteremia, MRSA PNA, and right sided pneumothorax requiring chest tube 1/17.   Dexamethasone (10 IV daily, day 15 on transfer), Remdesivir (s/p 10d), Toci (x1 dose), Rocephin/Zitro for CAP coverage -> decompensated on 12/21, ABX broadened to Levaquin/Merrem (day 15 total of ABX on transfer), empirically treated for PE w/ tLov -> intubated 12/22, developed sedation-related hypotension and started on Midorine   Patient's clinical course continued to worsen. She required CRRT and continued to required pressors and high ventilator settings. Patient's family made the decision to make patient DNR and transition to comfort care. She passed away with family at her bedside.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pneumonia staphylococcal, Pneumothorax, Positive airway pressure therapy, Pyrexia
Clinical narrative: Patient is a 69 yo F with PMH OSA, HTN, HLD, hypothyroidism, and depression who presents as an Outside facility information: I do not have phone number of hospital or a list of providers who cared for the patient at facility transfer for acute hypoxic respiratory failure due to COVID pneumonia requiring intubation. Patient is intubated / sedated with no family at bedside. History was obtained via chart review.    Patient had about 1 week of dyspnea, headache, fevers, cough, and nausea and was found to be COVID-19 positive on 12/8. Of note, patient was vaccinated with one dose of J&J vaccine. She was prescribed Decadron 4 mg daily, doxycycline, and an albuterol inhaler but failed to improve. She presented to Hospital on 12/12 and was found to be hypoxic with SaO2 76%. On admission, WBC 13K, CRP 17. CXR with b/l airspace disease. Her TTE showed EF 60%, mild LVH, normal left and right ventricular function. She was admitted to the Hospital ICU and started on remdesivir and continued on decadron. She was initially on 100% HFNC with ABG 7.43/46/81.   She clinically worsened on 12/12 with increased O2 requirements and received one dose of Amcetra 8 mg/kg. She was also started on ceftriaxone and azithromycin on 12/12. She continued to worsen and antibiotics were broadened to Levaquin and meropenem on 12/21. She was also started on therapeutic lovenox for suspected PE. She did not undergo a CT PE due to clinical instability. She was transitioned to BiPAP and then intubated on 12/22 for worsening hypoxia. She developed hypotension on propofol and was switched to versed and fentanyl drips for sedation and analgesia. She was also given midodrine for the hypotension.   On arrival to Higher Level of Care Facility, patient was on FiO2 100% and PEEP 10 with SaO2 in mid 90s. She was normotensive on fentanyl and versed drips.  Patient is a 69 y.o. female presenting from facility with AHRF on MV (Intubated 12/22) d/t COVID-19 PNA/ARDS (+12/8). Extubated on 1/5. Required reintubation 1/7 for respiratory distress. Course complicated by MRSA bacteremia, MRSA PNA, and right sided pneumothorax requiring chest tube 1/17.   Dexamethasone (10 IV daily, day 15 on transfer), Remdesivir (s/p 10d), Toci (x1 dose), Rocephin/Zitro for CAP coverage -> decompensated on 12/21, ABX broadened to Levaquin/Merrem (day 15 total of ABX on transfer), empirically treated for PE w/ tLov -> intubated 12/22, developed sedation-related hypotension and started on Midorine   Patient's clinical course continued to worsen. She required CRRT and continued to required pressors and high ventilator settings. Patient's family made the decision to make patient DNR and transition to comfort care. She passed away with family at her bedside.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiratory distress, SARS-CoV-2 test positive, Staphylococcal bacteraemia, White blood cell count increased
Clinical narrative: Patient is a 69 yo F with PMH OSA, HTN, HLD, hypothyroidism, and depression who presents as an Outside facility information: I do not have phone number of hospital or a list of providers who cared for the patient at facility transfer for acute hypoxic respiratory failure due to COVID pneumonia requiring intubation. Patient is intubated / sedated with no family at bedside. History was obtained via chart review.    Patient had about 1 week of dyspnea, headache, fevers, cough, and nausea and was found to be COVID-19 positive on 12/8. Of note, patient was vaccinated with one dose of J&J vaccine. She was prescribed Decadron 4 mg daily, doxycycline, and an albuterol inhaler but failed to improve. She presented to Hospital on 12/12 and was found to be hypoxic with SaO2 76%. On admission, WBC 13K, CRP 17. CXR with b/l airspace disease. Her TTE showed EF 60%, mild LVH, normal left and right ventricular function. She was admitted to the Hospital ICU and started on remdesivir and continued on decadron. She was initially on 100% HFNC with ABG 7.43/46/81.   She clinically worsened on 12/12 with increased O2 requirements and received one dose of Amcetra 8 mg/kg. She was also started on ceftriaxone and azithromycin on 12/12. She continued to worsen and antibiotics were broadened to Levaquin and meropenem on 12/21. She was also started on therapeutic lovenox for suspected PE. She did not undergo a CT PE due to clinical instability. She was transitioned to BiPAP and then intubated on 12/22 for worsening hypoxia. She developed hypotension on propofol and was switched to versed and fentanyl drips for sedation and analgesia. She was also given midodrine for the hypotension.   On arrival to Higher Level of Care Facility, patient was on FiO2 100% and PEEP 10 with SaO2 in mid 90s. She was normotensive on fentanyl and versed drips.  Patient is a 69 y.o. female presenting from facility with AHRF on MV (Intubated 12/22) d/t COVID-19 PNA/ARDS (+12/8). Extubated on 1/5. Required reintubation 1/7 for respiratory distress. Course complicated by MRSA bacteremia, MRSA PNA, and right sided pneumothorax requiring chest tube 1/17.   Dexamethasone (10 IV daily, day 15 on transfer), Remdesivir (s/p 10d), Toci (x1 dose), Rocephin/Zitro for CAP coverage -> decompensated on 12/21, ABX broadened to Levaquin/Merrem (day 15 total of ABX on transfer), empirically treated for PE w/ tLov -> intubated 12/22, developed sedation-related hypotension and started on Midorine   Patient's clinical course continued to worsen. She required CRRT and continued to required pressors and high ventilator settings. Patient's family made the decision to make patient DNR and transition to comfort care. She passed away with family at her bedside.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient is a 69 yo F with PMH OSA, HTN, HLD, hypothyroidism, and depression who presents as an Outside facility information: I do not have phone number of hospital or a list of providers who cared for the patient at facility transfer for acute hypoxic respiratory failure due to COVID pneumonia requiring intubation. Patient is intubated / sedated with no family at bedside. History was obtained via chart review.    Patient had about 1 week of dyspnea, headache, fevers, cough, and nausea and was found to be COVID-19 positive on 12/8. Of note, patient was vaccinated with one dose of J&J vaccine. She was prescribed Decadron 4 mg daily, doxycycline, and an albuterol inhaler but failed to improve. She presented to Hospital on 12/12 and was found to be hypoxic with SaO2 76%. On admission, WBC 13K, CRP 17. CXR with b/l airspace disease. Her TTE showed EF 60%, mild LVH, normal left and right ventricular function. She was admitted to the Hospital ICU and started on remdesivir and continued on decadron. She was initially on 100% HFNC with ABG 7.43/46/81.   She clinically worsened on 12/12 with increased O2 requirements and received one dose of Amcetra 8 mg/kg. She was also started on ceftriaxone and azithromycin on 12/12. She continued to worsen and antibiotics were broadened to Levaquin and meropenem on 12/21. She was also started on therapeutic lovenox for suspected PE. She did not undergo a CT PE due to clinical instability. She was transitioned to BiPAP and then intubated on 12/22 for worsening hypoxia. She developed hypotension on propofol and was switched to versed and fentanyl drips for sedation and analgesia. She was also given midodrine for the hypotension.   On arrival to Higher Level of Care Facility, patient was on FiO2 100% and PEEP 10 with SaO2 in mid 90s. She was normotensive on fentanyl and versed drips.  Patient is a 69 y.o. female presenting from facility with AHRF on MV (Intubated 12/22) d/t COVID-19 PNA/ARDS (+12/8). Extubated on 1/5. Required reintubation 1/7 for respiratory distress. Course complicated by MRSA bacteremia, MRSA PNA, and right sided pneumothorax requiring chest tube 1/17.   Dexamethasone (10 IV daily, day 15 on transfer), Remdesivir (s/p 10d), Toci (x1 dose), Rocephin/Zitro for CAP coverage -> decompensated on 12/21, ABX broadened to Levaquin/Merrem (day 15 total of ABX on transfer), empirically treated for PE w/ tLov -> intubated 12/22, developed sedation-related hypotension and started on Midorine   Patient's clinical course continued to worsen. She required CRRT and continued to required pressors and high ventilator settings. Patient's family made the decision to make patient DNR and transition to comfort care. She passed away with family at her bedside.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac function test, Dysphonia, Dyspnoea, Fall, Feeling abnormal
Clinical narrative: I never had psoriasis which I never had before. I started having trouble remembering things. I had foggy brain, could not remember names and I was a 911 dispatcher and I was just forgetting things. I also got rashes under my breasts and spotty ones in my stomach and arms. I could not get rid of them with any OTC medication. My doctor did not know what they were and I was referred me to a dermatologist. I was also having SOB. I also went to a neurologist. I was also referred to a rheumatologist and dermatologist. The doctor said I also had pleuritis in my eyes and I was given drops for my eyes. I went to an allergist after that and he wanted me to go to an eye doctor and the doctor said it was episcleritis both are some like to auto immune disease. I also saw a cardiologist with my SOB. The rash on my breasts looked weird and as put on intensive treatment and it was psoriasis. The cardiologist said I had coronary artery disease which was diagnosed this year. The psoriasis was diagnosed 6 months ago. I went to the eye doctor where they put little test strip to see how many tears I produced. My voice also has been hoarse sine the vaccine. I am not saying the covid vaccine caused this maybe it was due to a flareup or was triggered it. I also have been falling down unexpectedly and I do not know why I am having this symptoms. I am danger to myself, like I said I do not say that it is the vaccine, I feel more like it was trigger than a cause. Lot# was not provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Memory impairment, Ophthalmological examination, Pleurisy, Psoriasis, Rash
Clinical narrative: I never had psoriasis which I never had before. I started having trouble remembering things. I had foggy brain, could not remember names and I was a 911 dispatcher and I was just forgetting things. I also got rashes under my breasts and spotty ones in my stomach and arms. I could not get rid of them with any OTC medication. My doctor did not know what they were and I was referred me to a dermatologist. I was also having SOB. I also went to a neurologist. I was also referred to a rheumatologist and dermatologist. The doctor said I also had pleuritis in my eyes and I was given drops for my eyes. I went to an allergist after that and he wanted me to go to an eye doctor and the doctor said it was episcleritis both are some like to auto immune disease. I also saw a cardiologist with my SOB. The rash on my breasts looked weird and as put on intensive treatment and it was psoriasis. The cardiologist said I had coronary artery disease which was diagnosed this year. The psoriasis was diagnosed 6 months ago. I went to the eye doctor where they put little test strip to see how many tears I produced. My voice also has been hoarse sine the vaccine. I am not saying the covid vaccine caused this maybe it was due to a flareup or was triggered it. I also have been falling down unexpectedly and I do not know why I am having this symptoms. I am danger to myself, like I said I do not say that it is the vaccine, I feel more like it was trigger than a cause. Lot# was not provided.